There are 2934 resources available
5561 - FOxTROT: an international randomised controlled trial in 1053 patients evaluating neoadjuvant chemotherapy (NAC) for colon cancer.
Presenter: Dion Morton
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
2303 - Redefining the IGCCCG Classification in advanced Non-Seminoma
Presenter: Silke Gillessen
Session: Proffered Paper 2 – Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
5797 - Interim Evaluation of a Targeted Radiotherapeutic, CLR 131, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients (R/R DLBCL)
Presenter: Jarrod Longcor
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Abstract
Slides
Webcast
4267 - Bevacizumab for children with relapsed & refractory high risk neuroblastoma (RR-HRNB). Results of the BEACON-Neuroblastoma randomized phase 2 trial, a European ITCC-SIOPEN trial
Presenter: Lucas Moreno
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Abstract
Slides
Webcast
5966 - EONS - Opinions of palliative care patients and nurses regarding dignified care
Presenter: Yasemin Eskigulek
Session: EONS 12: Recent trends in palliative care
Resources:
Abstract
Slides
Webcast
2454 - EONS - Development of Core Indicators of Non-Specialist Palliative Care in Hospitals – An International Modified Delphi Study
Presenter: Mary Nevin
Session: EONS 12: Recent trends in palliative care
Resources:
Abstract
Slides
1090 - Talimogene laherparepvec (T-VEC) in combination (combo) with ipilimumab (ipi) versus ipi alone for advanced melanoma: 3-year landmark analysis of a randomized, open-label, phase 2 trial
Presenter: Jason Chesney
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
1989 - Phase II multicenter open label study of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study)
Presenter: Henrik Jespersen
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
3622 - Pembrolizumab for Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC): Efficacy and Safety Results From the Phase 2 KEYNOTE-629 Study
Presenter: Jean Jacques Grob
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
3904 - SELPAC - a 3 arm randomised Phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel (PT) in metastatic uveal melanoma (UM)
Presenter: Paul Nathan
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract